UNITED THERAPEUTICS CORP (UTHR)

US91307C1027 - Common Stock

274.26  +2.04 (+0.75%)

After market: 274.26 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to UTHR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 306.96. This target is 11.92% above the current price.
UTHR was analyzed by 22 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about UTHR.
In the previous month the buy percentage consensus was at a similar level.
UTHR was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 274.26222.20310.38306.96420.00 - -18.98% 13.17% 11.92% 53.14%
Up and Down Grades
Date Firm Action Rating
2024-05-03 Goldman Sachs Maintains Neutral -> Neutral
2024-05-02 Oppenheimer Maintains Outperform -> Outperform
2024-05-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-07 Wells Fargo Maintains Overweight -> Overweight
2024-02-22 Wedbush Reiterate Outperform -> Outperform
2024-02-22 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-12 Goldman Sachs Upgrade Sell -> Neutral
2024-02-05 Leerink Partners Initiate Outperform
2023-11-02 Wedbush Maintains Outperform -> Outperform
2023-11-02 JP Morgan Maintains Overweight -> Overweight
2023-11-02 Morgan Stanley Maintains Overweight -> Overweight
2023-08-03 Ladenburg Thalmann Maintains Buy -> Buy
2023-08-03 Wedbush Maintains Outperform -> Outperform
2023-08-03 Morgan Stanley Maintains Overweight -> Overweight
2023-08-03 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-04 Ladenburg Thalmann Maintains Buy
2023-04-21 Argus Research Maintains Buy
2023-04-10 UBS Maintains Buy
2023-04-10 Morgan Stanley Maintains Overweight
2023-02-23 JP Morgan Maintains Overweight
2023-02-23 Morgan Stanley Maintains Overweight
2023-02-23 HC Wainwright & Co. Reiterate Buy
2023-01-11 Argus Research Maintains Buy
2022-12-06 UBS Initiate Buy
2022-12-06 Morgan Stanley Maintains Overweight
2022-12-05 Goldman Sachs Initiate Sell
2022-11-03 Oppenheimer Maintains Outperform
2022-11-03 JP Morgan Maintains Overweight
2022-11-03 Morgan Stanley Maintains Overweight
2022-11-03 HC Wainwright & Co. Maintains Buy